PUBLIC COMPANY
saveCYCLE
USupdated 6mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- AstraZeneca cuts early-phase prostate cancer pipelineAstraZeneca has punted a pair of early-phase prostate cancer programs as part of its quarterly pipeline clearout.fiercebiotech · 6h ago
- LENZ cuts 75% of staff as third quarter earnings disappointFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 22h ago
- Opinion: Freezing my eggs showed me just how anti-feminist the fertility industry can be“A few years ago, I froze my eggs — and the experience was anything but empowering,” writes physician Pooja Yerramilli.stat · 2d ago
- The 4 stages of women’s heart health: New framework for doctors and patientsNew guidance is intended to help girls and women — and their doctors — recognize four distinct phases in heart health.stat · 4d ago
- ESMO: Zentalis already dreaming of launch for WEE1 inhibitor after ‘great result’ in early-stage testZentalis Pharmaceuticals has pointed to the first overall survival (OS) analysis for azenosertib as proof that the oral WEE1 tyrosine kinase inhibitor can offer a convenient oral treatment for a tr…fiercebiotech · 8d ago
- Tarver: CDRH on a ‘recruiting tear,’ looking ahead to MDUFA VIBOSTON – Top US Food and Drug Administration (FDA) medical device officials said they are focused on restaffing after last year’s reduction-in-force (RIF) and are optimistic about the Medical Devic…raps · 9d ago
- Rapport’s epilepsy drug finds surprising success in bipolar trialDespite what some analysts described as low expectations, RAP-219 narrowly hit the main goal of a mid-stage study, results that could help it tap a billion-dollar-plus market opportunity.biopharma_dive · 9d ago
- Rapport ekes out bipolar mania win as lead asset ‘just hits’ in mid-stage trialRapport Therapeutics clocked its second Phase 2 win in 14 months for RAP-219—which the company is positioning as a potential pipeline-in-a-product—this time showing improvement in symptoms of bipol…biospace · 9d ago
- Extractables in single-use systems used in ADC manufacturingExplore extractables data supporting single-use systems in ADC manufacturing.biopharma_dive · 11d ago
- From strategy to scale: How Saudi Arabia is building a biotech ecosystemSaudi Arabia’s biotech strategy now has named partners, sites and capital behind it.biopharma_dive · 11d ago
comments(0)
5-min edit window · permanent after that